Wotnews is an Australian news monitoring service. Register FREE to monitor Peplin.

Peplin
46 search results

Highlights this month
4 hours, 55 minutes ago Peplin director buys off-market
Peplin director buys off-market... 02 Dec 2008 11:54 AM
Business Spectator health & pharmaceuticals - 10:54 a.m. Tuesday 2nd December 2008
Coverage & Analysis View Article Email to Friend
Peplin ready to begin phase III testing
Peplin Incorporated (PLI) said as of the quarter ended 30 September 2008, it had a pro-forma cash position of US$43.6 million ($68.2 million). The company said that as a result ...
ninemsn Money - 9:53 a.m. Tuesday 2nd December 2008
Coverage & Analysis View Article Email to Friend
Peplin ready to begin phase III testing
Peplin Incorporated (PLI) said as of the quarter ended 30 September 2008, it had a pro-forma cash position of US$43.6 million ($68.2 million). The company said that as a result ...
Live News Business - 9:26 a.m. Tuesday 2nd December 2008
Coverage & Analysis View Article Email to Friend
16 hours, 49 minutes ago Peplin ready to begin phase III testing
Peplin said as of the quarter ended 30 September 2008, it had a pro-forma cash position of US$43.6m and as a result would be able to fund phase III testing ...
Live News Business - 11 p.m. Monday 1st December 2008
Coverage & Analysis View Article Email to Friend
3 weeks ago Peplin directors buy 10k CDIs
Peplin directors buy 10k CDIs... 11 Nov 2008 14:19 PM
Business Spectator director dealings - 1:19 p.m. Tuesday 11th November 2008
Coverage & Analysis View Article Email to Friend
1 month ago Peplin appoints director
Peplin appoints director... 29 Oct 2008 15:04 PM
Business Spectator health & pharmaceuticals - 2:04 p.m. Wednesday 29th October 2008
Coverage & Analysis View Article Email to Friend
1 month, 1 week ago Peplin completes Neosil buy
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world. Peplin has completed its US$6.7 million purchase of private ...
Life Scientist - 10:35 a.m. Thursday 23rd October 2008
Coverage & Analysis View Article Email to Friend
1 month, 3 weeks ago Peplin directors issued plan securities
Peplin directors issued plan securities... 10 Oct 2008 18:35 PM
Business Spectator health & pharmaceuticals - 5:35 p.m. Friday 10th October 2008
Coverage & Analysis View Article Email to Friend
1 month, 3 weeks ago Peplin pay packages under fire
PAY packages came under fire yesterday at an investor meeting for skin cancer researcher Peplin, which is developing a gel based on a weed sap. Smaller stockholders also asked about ...
Business Sense - 12:18 a.m. Tuesday 7th October 2008
Coverage & Analysis View Article Email to Friend
1 month, 3 weeks ago Peplin pay packages under fire
PAY packages came under fire yesterday at an investor meeting for skin cancer researcher Peplin, which is developing a gel based on a weed sap.
Herald Sun - 11 p.m. Monday 6th October 2008
Coverage & Analysis View Article Email to Friend
2 months, 2 weeks ago Peplin director buys 23.4k CDIs
Peplin director buys 23.4k CDIs... 19 Sep 2008 12:22 PM
Business Spectator health & pharmaceuticals - 12:22 p.m. Friday 19th September 2008
Coverage & Analysis View Article Email to Friend
2 months, 2 weeks ago Peplin ready to begin phase III testing
10:43 AM
ninemsn Business News - midnight Monday 15th September 2008
Coverage & Analysis View Article Email to Friend
2 months, 3 weeks ago Trial for sun spot gel
BIOTECH company Peplin has begun phase three clinical trials of its skin cancer gel for the treatment of sun spots and pre-cancerous lesions.
The Australian Business News - midnight Wednesday 10th September 2008
Coverage & Analysis View Article Email to Friend
2 months, 3 weeks ago (AEPLI) Peplin starts Phase III clinical trial for PEP005 Gel
Sydney - Tuesday - September 9: (RWE Australian Business News) - Peplin Inc (ASX:PLI) today announced the initiation of its first Phase III clinical trial to confirm the efficacy and ...
TherapeuticsDaily - 9:14 p.m. Tuesday 9th September 2008
Coverage & Analysis View Article Email to Friend
Cutler Innovation Review; Starpharma Up 60% On Durex Deal; Peplin Begins Phase III Trial
The 206-page Review of the National innovation System by Dr Terry Cutler says more about government procedures than biotechnology; Starpharma signs $100 million Durex licence to coat condoms with its ...
Biotech Daily - 5:25 p.m. Tuesday 9th September 2008
Coverage & Analysis View Article Email to Friend
1234>

Gold Coast Hotels from $99
Related Publishers
Business Spectator ...
Life Scientist
Plugger Email ...
Pharmalive
TherapeuticsDaily
Herald Sun
Courier Mail ...